Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche's Tecentriq/Cotellic combo therapy fails to impress in colorectal cancer

pharmafileMay 15, 2018

Tag: Roche's , Tecentriq/Cotellic combo , in colorectal cancer

PharmaSources Customer Service